| Market Cap | 2.96K | P/E | - | EPS this Y | - | Ern Qtrly Grth | - |
| Income | -1.67M | Forward P/E | - | EPS next Y | - | 50D Avg Chg | -99.00% |
| Sales | 1.82M | PEG | - | EPS past 5Y | - | 200D Avg Chg | -99.00% |
| Dividend | N/A | Price/Book | 0.00 | EPS next 5Y | - | 52W High Chg | -100.00% |
| Recommedations | - | Quick Ratio | 0.78 | Shares Outstanding | 2.48B | 52W Low Chg | - |
| Insider Own | - | ROA | 8.72% | Shares Float | - | Beta | -0.43 |
| Inst Own | - | ROE | - | Shares Shorted/Prior | -/- | Price | 0.00000 |
| Gross Margin | 98.18% | Profit Margin | -91.47% | Avg. Volume | 213,761 | Target Price | - |
| Oper. Margin | -0.50% | Earnings Date | - | Volume | 34,500 | Change | 0.00% |
Patient Access Solutions, Inc. provides healthcare/financial processing solutions for the healthcare and dental industries. The company, through its merchant processing platform, provides patient eligibility, medical billing, and patient self-pay solutions. It also provides practice management, business management consulting, GAP analysis, and marketing and practice development services; and treatment services for autism, concussion, PTSD, and other biomedical conditions, as well as diagnostic testing services. Patient Access Solutions, Inc. is based in Plainview, New York.
